These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10434158)

  • 1. [Is there a relationship between clinical efficacy and antidepressant dosage in major depression?].
    Corruble E; Guelfi JD
    Encephale; 1999 Jun; 25 Spec No 2():39-43; discussion 44-6. PubMed ID: 10434158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of venlafaxine and imipramine in depressive illness.
    Rajagopalan M
    Acta Psychiatr Scand; 1998 May; 97(5):384-5. PubMed ID: 9611090
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.
    Einarson TR; Arikian SR; Casciano J; Doyle JJ
    Clin Ther; 1999 Feb; 21(2):296-308. PubMed ID: 10211533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venlafaxine versus SSRI therapy for major depression. Results of comparative efficacy trials.
    Bakish D
    Postgrad Med; 1999 Nov; 106(6 Suppl):24-30. PubMed ID: 19667501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of venlafaxine in the treatment of severe depression.
    Kienke AS; Rosenbaum JF
    Depress Anxiety; 2000; 12 Suppl 1():50-4. PubMed ID: 11098414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study.
    McIntyre A; Gendron A; McIntyre A
    Depress Anxiety; 2007; 24(7):487-94. PubMed ID: 17177199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia.
    Benkert O; Gründer G; Wetzel H; Hackett D
    J Psychiatr Res; 1996; 30(6):441-51. PubMed ID: 9023787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
    Debonnel G; Saint-André E; Hébert C; de Montigny C; Lavoie N; Blier P
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):51-61. PubMed ID: 16690006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine extended-release: a review of its use in the management of major depression.
    Wellington K; Perry CM
    CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant use during pregnancy. FPIN’s clinical inquiries.
    Patel BN; Beste J; Blackwell JC
    Am Fam Physician; 2011 May; 83(10):1211-5. PubMed ID: 21568258
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of high-dose venlafaxine-related psychosis.
    Dennison EA; Raidoo BM; Cruz R; Raidoo D
    J Clin Psychopharmacol; 2013 Feb; 33(1):134-6. PubMed ID: 23288238
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
    Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
    Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response relationship with venlafaxine.
    Kelsey JE
    J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):21S-26S; discussion 26S-28S. PubMed ID: 8784645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of bupropion with SRIs and venlafaxine.
    Spier SA
    Depress Anxiety; 1998; 7(2):73-5. PubMed ID: 9614595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venlafaxine and treatment-resistant depression.
    Thase ME; Friedman ES; Howland RH
    Depress Anxiety; 2000; 12 Suppl 1():55-62. PubMed ID: 11098415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.
    Blier P; Saint-André E; Hébert C; de Montigny C; Lavoie N; Debonnel G
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):41-50. PubMed ID: 16690005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine: new preparation. Just another antidepressant.
    Prescrire Int; 1998 Aug; 7(36):112-4. PubMed ID: 10342950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Gee MD; Krishen A; Wunderlich HP; Le Clus A; Evoniuk G; Modell JG
    J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.